glipizide has been researched along with Amyloidosis in 1 studies
Glipizide: An oral hypoglycemic agent which is rapidly absorbed and completely metabolized.
glipizide : An N-sulfonylurea that is glyburide in which the (5-chloro-2-methoxybenzoyl group is replaced by a (5-methylpyrazin-2-yl)carbonyl group. An oral hypoglycemic agent, it is used in the treatment of type 2 diabetes mellitus.
Amyloidosis: A group of sporadic, familial and/or inherited, degenerative, and infectious disease processes, linked by the common theme of abnormal protein folding and deposition of AMYLOID. As the amyloid deposits enlarge they displace normal tissue structures, causing disruption of function. Various signs and symptoms depend on the location and size of the deposits.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hoenig, M | 1 |
| Hall, G | 1 |
| Ferguson, D | 1 |
| Jordan, K | 1 |
| Henson, M | 1 |
| Johnson, K | 1 |
| O'Brien, T | 1 |
1 other study available for glipizide and Amyloidosis
| Article | Year |
|---|---|
A feline model of experimentally induced islet amyloidosis.
Topics: Amyloid; Amyloidosis; Animals; Cats; Dexamethasone; Diabetes Mellitus, Type 2; Disease Models, Anima | 2000 |